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REACH Medical University of South Carolina (MUSC) provides stroke consults via the
internet in South Carolina. From May 2008 to April 2011 231 patients were treated with
intravenous (IV) thrombolysis and 369 were transferred to MUSC including 42 for intra-
arterial revascularization [with or without IV tissue plasminogen activator (tPA)]. Medical
outcomes and hemorrhage rates, reported elsewhere, were good (Lazaridis et al., 2011).
Here we report operational features of REACH MUSC which covers 15 sites with 2,482
beds and 471,875 Emergency Department (ED) visits per year. Eight Academic Faculty
from MUSC worked with 165 different physicians and 325 different nurses in the conduct
of 1085 consults. For the 231 who received tPA, time milestones (in minutes) were: Onset
to Door: 62 (mean), 50 (median); Door to REACH Consult: 43 and 33, Consult Request to
Consult Start: was 9 and 7, Consult Start to tPA Decision: 31 and 25; Decision to Infusion:
20 and 14, and total Door to Needle: 98 and 87. The comparable times for the 854 not
receiving tPA were: Onset to Door: 140 and 75; Door to REACH Consult: 61 and 41; Con-
sult Request to Consult Start: 9 and 7, Consult Start to tPA Decision: 27 and 23.While the
consultants respond to consult requests in <10, there is a long delay between arrival and
Consult request. Tracking of operations indicates if we target shortening Door to Call time
and time from tPA decision to start of drug infusion we may be able to improve Door to
Needle times to target of<60.The large number of individuals involved in the care of these
patients, most of whom had no training in REACH usage, will require novel approaches to
staff education in ED based operations where turnover is high. Despite these challenges,
this robust system delivered tPA safely and in a high fraction of patients evaluated using
the REACH MUSC system.
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INTRODUCTION
South Carolina has one of the highest rates of stroke and many
of the strokes occur in smaller communities that lack expert stoke
care in their hospitals (Lackland et al., 1998). Stroke can be treated
with a clot busting drug (Alteplase) but this drugmust be initiated
within 3 hours after stroke to have the best chance for beneﬁt and
in any case before 4.5 hours (del Zoppo et al., 2009). TheAmerican
Stroke Association recently published evidence that supported the
use of telemedicine for acute stroke (Schwamm et al., 2009a). The
Stroke Systems of Care Model (SSCM) recommends implemen-
tation of telemedicine to increase access to acute stroke care in
neurologically underserved areas (Schwamm et al., 2009b).
Telemedicine systems for stroke are now gaining use, and since
rapid treatment is of great importance in stroke, it is of interest
that their operations be analyzed to identify possible sources of
treatment delays and areas where improvements can be made.
MATERIALS AND METHODS
THE NETWORK, SITE SELECTION, AND INITIATION
Potential sites were contacted by the Director (Robert J. Adams,
MS,MD)basedon anumber of factors including known interest in
improving stroke care, proximity to Medical University of South
Carolina (MUSC), prior relationship with MUSC for provision
of other services, or professional associations with neurologists
in target communities. MUSC had no direct corporate ties with
these sites. Servicewas provided to sites according to two contracts:
one contract was with the platform vendor REACH Health, Inc.
(Augusta, Georgia) and a separate one was with MUSC (MUSC
Neurosciences) for the provision of the neurological consultation.
Theﬁrst contract covered the provisionof the cart, technical instal-
lation, training and maintenance as well as 24/7 technical support
by phone. The second spelled out the relationship wherebyMUSC
stroke specialists would provide, as credentialed consultants, the
consultative services (REACH MUSC based in the Department of
Neuroscience). The cost of neurological service (REACH MUSC)
was based on total yearly ED volume, a number which we believed
to bemore readily available and reliable than indices more directly
related to stroke. Sites paid a daily “readiness fee,” which was ﬁxed
for the term of the contract (typically 2 years) and did not vary
with usage.
Remote Evaluation of Acute Ischemic Stroke (REACH)MUSC
provided at start of site service initiation a half day clinical training
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course on stroke emphasizing acute management and given to the
site in an enduring medium with the suggestion that all Emer-
gency Department (ED) personnel view the training course when
convenient. However, no systematic program of re-education or
feedback to the sites as to operational performance was initiated.
The sites were told at outset that our preferred mode of operation
would be for them to initiate a consult based on the history of
stroke like symptoms observed within 8 hours of presentation,
regardless of the patient’s current status (e.g., still call even if
improved) and to initiate the call at the time the patient is sent
to the CT scanner (not after CT has been performed).
CONSULTATION PROCESS
Each spoke has a wireless “REACH cart” (a mobile unit composed
of a computer, LCD screen, and camera onwheels) pre-installed in
their ED. (The cart, software, and system integration is provided
by REACH Health, Inc., of Augusta, Georgia – REACH 3.0 ver-
sion). When a suspected stroke patient arrives in the ED, the sites
are instructed to perform a rapid triage and examination similar
to what any stroke center ED would provide. When the patient
is sent for a cranial CT the site enters the name, time last seen
normal, weight, and blood pressure into the program which then
“registers” the patient as an active consult. They then call MUSC
Admit Transfer Center (ATC) and request a “REACH Stroke con-
sult.” It is key that the term “REACH”be used to distinguish these
from ordinary telephone consultations for transfers and the like
which may originate from any location, not just a REACH MUSC
site.
The ATC sends out a page and a repeat in 5minutes and then
in 3minutes until a consultant calls the ATC and is connected
to the spoke site. ATC also receives information from sites on
patients that are transferred and if needed facilitates helicopter or
ambulance transfer.
While in telephone contact the consultant logs into the REACH
secure website from any location with internet access. The com-
puter must be a PC, with Active X downloaded but otherwise
requires no special outﬁtting. Logging in requires two security
steps which when they are completed delivers the consultant to
a webpage where he/she selects the consult to join (if there is
more than one in progress), and views the patient information
and the video of the patients room in one part of the screen.
The camera is equipped with fully adjustable zoom and direc-
tional change capability. With the help of the spoke RN, and a
speaker phone, the consultant interviews patient, family, ED staff,
whomever may be able to provide useful information relevant to
the tissue plasminogen activator (tPA) decision. The nurse assists
the consultant in performing the NIHSS. The CT scan is “pushed”
to the REACH Health, Inc. website and is usually available by the
time the NIHSS is completed. The next step is typically a con-
versation with the spoke ED physician and a decision, ideally a
mutual one, about what the consultant will indicate in terms of
the advisability of tPA.
Clicking “For tPA” displays a weight based protocol which the
consultant approves and is then displayed at the spoke for their
use. Clicking “Against tPA” displays a list of contraindication from
which the consultant can choose one ormore reasons why tPAwas
not recommended.
The website has spaces for a complex note in “SOAP” format.
That is, if the NIHSS is not ﬁlled out, a prompt will appear requir-
ing an override but the consultant could proceed without doing
the NIHSS although this was discouraged.
Further “decision support” that is built into the REACH 3.0
version includes: (1) time remaining in 3 and 4.5 hour windows;
warning if INR is>1.7; (2) reminder to ﬁll out key ﬁelds especially
NIHSS before closing; (3) reminder to sign consult before closing;
(4) Procedure Decision and follow-up items were required before
closing the consult; (5) REACH 3.0 software provides a prompt
if blood pressure exceeds 185mm systolic or 115mm diastolic
and informs the consultant for platelets <100 thousand, Partial
Thromboplastin Time >40 s, Prothrombin Time >15 s, Interna-
tional Normalized Ratio >1.7 and Blood Glucose <50mg/dL or
>400mg/dL by displaying a prompt if these limits are violated.
Prompts can be manually overridden. There is also a space for
entering feedback to the vendor provider or system project man-
ager if either technical or site operational problems are encoun-
tered and these comments do not appear on the spoke side or
on the ﬁnal consult. Email notiﬁcations are sent at the time of
patient registration, time of consult initiation, and completion to
any number of prespeciﬁed addresses.
The treating physician was the ED physician on site who, after
considering the formal MUSC consultants input typically decided
among these options:“drip (Alteplase) and transport,”or“drip and
keep (hospitalize locally),” or “evaluate (no Alteplase) and trans-
port,”or“evaluate and keep.”Sites could also useREACHMUSC to
make theAlteplase decision then send the patient to a facility other
than MUSC, but this rarely happened. The REACH MUSC con-
sultants have consulting privileges at each spoke site and include
7 board certiﬁed vascular neurologists and 1 emergency medicine
physician with extensive stroke interest and experience.
OPERATIONAL ANALYSIS
The consult form and CT scan, but not the video, are stored long
term by REACH Health, Inc. and are available for printing and
storage at the site immediately after the consult is completed and
closed or for later review as in this report. The consultant can
retrieve the consult from the REACH Health, Inc. website imme-
diately and send via email as a PDF, and selected JPEG’s from the
CT if desired, to “downstream” caregivers, for example, using a
group emailing of the ﬁles to physicians at the hub who will be
receiving the patient in transfer and provide cell phone numbers of
key family members who may be in transit when a crucial follow-
up treatment decision, such as intra-arterial clot removal, need to
be urgently discussed. To report operational aspects of this pro-
gram we examined all the REACH consults according to an IRB
approved protocol.
RESULTS
NETWORK CONFIGURATION
Thenetwork conﬁguration as of June 30,2011 is shown inFigure 1.
The closest spokewas 61miles away and the furthest 191mileswith
the average 126miles. From initial contact and expression of inter-
est to “going live” about 6months typically elapsed, most of that
time spent in contract review and ﬁnalization and credentialing
of consultants. The system expanded over time so that at the end
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FIGURE 1 | REACH MUSC site map.
Table 1 | REACH MUSC network information.
Site Start date # Hospital
beds
Annual
ED visits
Distance to
MUSC (miles)
1 5/1/2008 131 31,990 61
2 5/6/2008 140 24,000 82
3 5/7/2008 453 63,000 133
4 9/1/2008 220 62,000 102
5 9/18/2008 124 23,885 119
6 12/23/2008 25 11,000 74
7 1/20/2010 45 18,000 88
8 3/26/2010 288 46,000 187
9 5/21/2010 121 24,000 148
10 7/29/2010 79 25,000 163
11 8/25/2010 231 30,000 176
12 10/1/2010 116 33,000 143
13 2/28/2011 105 20,000 117
14 2/28/2011 50 20,000 116
15 3/2/2011 354 40,000 191
of 2008 there were 5 spokes, at end of 2009 there were 6, by end
of 2010 there were 11 and 15 as of January 3, 2011. The network
sites varied in size from a small “critical access” site (Table 1) with
25 beds to a large private non-proﬁt regional medical center with
453 beds.
SUMMARY OF OPERATIONS
The overall consultation statistics are shown in Table 2. Of the
1,085 patients evaluated, 255 were recommended for treatment
with tPA and of this set tPA was initiated in 231 cases. Of the
24 patients that were recommended to receive, but did not get
tPA, 9 were the result of patient decision, 5 were due to the fam-
ily’s preference, 1 had sustained high blood pressure, and 9 were
due to unknown/undocumented conditions (probably a clinical
improvement post consult). During the conduct of these consults,
Table 2 | REACH overall data.
REACH totals
Total consults 1,085
Transferred to MUSC 369 (34%)
tPA patients 231 (21%)
Interventional radiology (transferred patients only) 42 (11%)
Table 3 | REACH operational times (in minutes) for patients that
received tPA (n=231).
REACH tPA
patients
MEAN MEDIAN MIN MAX STDEV
Symptom onset to ED door 62 50 0 210 43
ED door to consult request 43 33 2 273 37
Consult request to MD logon 9 7 1 51 7
Consult start to tPA decision 31 25 5 173 22
tPA decision to tPA
administration
20 14 0 85 19
ED door to needle 98 87 26 290 40
Symptom onset to needle 160 150 50 314 54
Total consult time 46 38 11 182 30
156 different physicians initiated a consult and 346 different nurses
assisted the consultant.
Time milestones are shown in Table 3. We separated the con-
sults into those getting tPA and those who did not to examine
the possible impact of informal early “curbside” decisions by the
spoke team regarding tPA use (possibly moving more slowly since
tPA was not going to be used). The outcomes of those treated with
tPA and hemorrhage rates are reported elsewhere. The sympto-
matic hemorrhage rate was 3% and just over 50% went home.
Asymptomatic hemorrhage was discovered in an additional 7% of
patients.
Early afternoon during the hour of 12–1:00 pm (n= 76, 7%)
was the most likely time for a consult to occur, and the least was
5:00–6:00 am (n= 8, 0.7%; nominal fraction expected would be
4.2%).
For the 231 who received tPA, key timemilestones (in minutes)
were: Onset to Door: 62 (mean), 50 (median); From when they
arrived to when the ATC was called by the spoke (Door to REACH
Consult) 43 and 33, Consult Request to Consult Start was 9 and 7,
Consult Start to tPA Decision: 31 and 25; Decision to Infusion: 20
and 14, and Door to Needle: 98 and 87. The comparable times for
the 854 not receiving tPA were: Onset to Door: 140 and 75; Door
To REACH Consult: 61 and 41; Consult Request to Consult Start:
9 and 7, Consult Start to tPA Decision: 27 and 23.
DISCUSSION
These data suggest that tPA facilitated by REACH MUSC, while
associated with hemorrhage rates that are well within accepted
benchmarks, falls short of reaching the NIHSS guideline of
60minute Door to Needle time. This analysis pinpoints the opera-
tional problems. The symptomonset to door average of 58minutes
means that if we could bring our door to needle time to 60minutes
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or less we would be initiating treatment at a median of 2 hours,
whichwould probably lead to better outcomes givenwhatwe know
about the impact of time to treatment on outcome (Wardlaw et al.,
1997).
The main task is reducing the Door to Consult time. The
goal over the next year is to bring this key operational value to
15minutes or less. At the outset a yearly retraining was envisioned
but this did not happen because the administrative capacity was
consumed in building out the network. As a result there are many
individuals involved in the consults whowere not part of the initial
training. To address this, a newsletter was published in December
2011 and REACH MUSC sites were invited in 2011 to a series
of 6 stroke lectures video cast through the statewide Area Health
Education Consortium but spoke participation was not tracked.
CONCLUSION
Door to Needle times in the REACH MUSC network are beyond
the target of 60minutes and need to be reduced. The most likely
targets are reduction in “door to call time” and the delay to infu-
sion after tPA is recommended. The many individuals involved in
using the service at the spoke end pose special training challenges
that may require novel methods.
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